Directory
>
Laura Sanftner
Laura Sanftner
Post-doctoral fellow, Neuroscience | Novo Nordisk
California, Lafayette, United States
Laura Sanftner
Summary
Laura Sanftner is an accomplished Executive Director specializing in Toxicology and Pharmacology with over 20 years of experience in drug development. Currently leading toxicology strategy at Dicerna, a TRU of Novo Nordisk, she has a proven track record in overseeing regulatory submissions and managing cross-functional collaborations. Laura's expertise extends to budget management and vendor selection, underscoring her strategic approach to nonclinical development. With a strong educational background from UC Berkeley, including a PhD in Neuroscience, she has contributed significantly to the field through her leadership roles at Plexxikon Inc. Laura's commitment to innovation in drug development is evident in her active engagement with regulatory agencies and her focus on advancing therapeutic solutions.
Laura Sanftner
Work Experience
Executive Director, Toxicology Program Development at
Novo Nordisk
April 2022 - Present
Laura Sanftner
Education
University of California, Berkeley, PhD, Neuroscience
January 2000 - January 2000
University of California, Berkeley, BS, Molecular and Cell Biology, Neurobiology emphasis
Frequently Asked Questions about Laura Sanftner
What is Laura Sanftner email address?
Laura Sanftner's primary email address is ********@novonordisk-us.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Laura Sanftner work for?
Laura Sanftner is a Post-doctoral fellow, Neuroscience at Novo Nordisk.
Where Laura Sanftner graduated from?
Laura Sanftner holds a degree in from University of California, Berkeley.
How can I directly contact Laura Sanftner?
To contact Laura Sanftner directly, you can use the email address ********@novonordisk-us.com. Complete contact information is available upon registration with Muraena.
Who is Laura Sanftner?
Laura Sanftner is an accomplished Executive Director specializing in Toxicology and Pharmacology with over 20 years of experience in drug development. Currently leading toxicology strategy at Dicerna, a TRU of Novo Nordisk, she has a proven track record in overseeing regulatory submissions and managing cross-functional collaborations. Laura's expertise extends to budget management and vendor selection, underscoring her strategic approach to nonclinical development. With a strong educational background from UC Berkeley, including a PhD in Neuroscience, she has contributed significantly to the field through her leadership roles at Plexxikon Inc. Laura's commitment to innovation in drug development is evident in her active engagement with regulatory agencies and her focus on advancing therapeutic solutions.
Laura`s contact details
********@novonordisk-us.com
*********@plexxikon.com
Colleagues
Physician
Project Manager
Campaign Manager - SEM
Quality operation director
Finance Assistant
CALIBRATION AND SERVICE MGR
Commissioner's Fellow
Broadcast Intern
Student Assistant
DIRECTOR – B2B & CONSUMER DIGITAL SELF SERVICE